Psoriasis Drugs Market

Global Psoriasis Drugs Market: Overview 

In recent times, there is rise in prevalence of psoriasis owing to the changes in lifestyle such as high consumption of alcohol and sedentary living. This has resulted in a rise in production of psoriasis drugs, thereby contributing to the market’s expansion. The global psoriasis market is expected to witness an exponential growth during the forecast period owing to an increase in awareness regarding treatment and advancements in medical technology. 

Global Psoriasis Drugs Market: Notable Developments 

Below are a few notable developments in the global psoriasis drugs market:

 The use of biologics in the treatment of psoriasis has presented numerous growth prospects for the global psoriasis drugs market. Biologics are medicines made out of substances found in living things. They are injected in the bloodstream in order to block tumor necrosis, the factor responsible sending messages to the immune system. This results in the reduction of the autoimmune response, thereby stopping the disease from spreading. 

• Development of Apremilast (Otezla) is one of the major advancements in treatment of psoriasis. It suppresses the interleukin-17 (IL17) and IL23 that play a key role in psoriasis pathogenesis. Moreover, it regulates the inflammation within the cell. It is licensed to treat both psoriatic arthritis and chronic plaque psoriasis, thereby aiding the growth of global psoriasis drugs market. 

Prominent players in the psoriasis drugs market include Johnson & Johnson, Eli Lilly & Company, Celgene Corporation, Merck, and AstraZeneca. 

Global Psoriasis Drugs Market: Key Growth Dynamics 

An increase in investment on biologics and rising awareness regarding the disease are the key factors contributing to the growth of global psoriasis drugs market. This has also contributed to the development of new diagnostics and a surge in the use of psoriasis therapeutics. Additionally, the environmental factors triggering the diseases have highly contributed to the market’s expansion. 

The evolvement in the psoriatic treatment with the introduction of new drugs and therapies and an extensive use of combination drugs has highly driven the growth of psoriasis drugs market. The effects of psoriasis are debilitating and can result in anxiety in some patients. Consequently, there is a rise in adoption of minimally invasive psoriasis therapies that offer effective results in minimal time. This has affected the market favourably, thereby steering its growth. 

In addition to the above drivers, rising adoption of Interleukin inhibitors owing to the efficacy they offer is a key factor driving the growth of global psoriasis drugs market. Moreover, some patients are intolerant to other psoriasis therapies leading to an extensive use of Interleukin inhibitors. 

However, along with the numerous driving factors there are some restraint’s that may impede the progression of psoriasis drugs market. Factors such as side effects of the psoriasis drugs and less accessibility psoriasis treatment options in the underdeveloped and remote areas may cause a shortfall in the market, Nevertheless, favourable government initiatives and increasing prevalence of prominent psoriasis drug manufacturers may present several growth opportunities for the psoriasis drugs market. 

Global Psoriasis Drugs Market: Regional Outlook 

On the geographical front, North America is expected to lead the global psoriasis drugs market. This is owing to the advancements in healthcare facilities and rising prevalence of psoriasis. U.S. is the major contributor to the market’s growth in this region. Japan is anticipated to grow steadily during the forecast period owing to easy access to treatment and high disposable income.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

• Market segments and sub-segments
• Market trends and dynamics
• Supply and demand
• Market size
• Current trends/opportunities/challenges
• Competitive landscape
• Technological breakthroughs
• Value chain and stakeholder analysis

The regional analysis covers:

• North America (U.S. and Canada)
• Latin America (Mexico, Brazil, Peru, Chile, and others)
• Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
• Eastern Europe (Poland and Russia)
• Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
• Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

• A complete backdrop analysis, which includes an assessment of the parent market
• Important changes in market dynamics
• Market segmentation up to the second or third level
• Historical, current, and projected size of the market from the standpoint of both value and volume
• Reporting and evaluation of recent industry developments
• Market shares and strategies of key players
• Emerging niche segments and regional markets
• An objective assessment of the trajectory of the market
• Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.